BioScience Health Innovations (BHIC) Receivables - Other (2024 - 2025)
BioScience Health Innovations (BHIC) posted quarterly Receivables - Other of $137718.0 for Q4 2025, up 531.79% year-over-year from $21798.0 in Q4 2024, and up 531.79% quarter-over-quarter from $21798.0 in Q4 2024.
BioScience Health Innovations (BHIC) Receivables - Other (2024 - 2025) Analysis & Trends
BioScience Health Innovations (BHIC) has reported Receivables - Other for 2 consecutive years, with $137718.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Receivables - Other rose 531.79% year-over-year to $137718.0; the TTM figure through Dec 2025 stood at $137718.0 (up 531.79% YoY), while the FY2025 annual figure was $137718.0, up 531.79% from the prior year.
- Receivables - Other climbed to $137718.0 in Q4 2025 per BHIC's latest filing, from $21798.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $137718.0 in Q4 2025 and bottomed at $21798.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | High Tide | 215.72 Mn | 182.44 Mn | 35.30 Mn |
| 2 | BioScience Health Innovations | 58.76 Mn | 58.05 Mn | 659,483.00 |
| 3 | Petmed Express | 38.29 Mn | 25.19 Mn | 11.33 Mn |
| 4 | Scienture Holdings | 17.71 Mn | 17.71 Mn | 335,779.00 |
| 5 | Polomar Health Services | 8.48 Mn | 8.31 Mn | 935,916.00 |
| 6 | Ridgetech | 58,214.34 | -17.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 137,718.00 |
| Dec 31, 2025 | 137,718.00 |
| Dec 31, 2024 | 21,798.00 |
| Dec 31, 2024 | 21,798.00 |